Wikidata |

Wikidata

Matches in Wikidata for { <http://www.wikidata.org/entity/Q38558536> ?p ?o ?g. }

Showing items 1 to 100 of ±116 with 100 items per page.

Q38558536 description "2016 nî lūn-bûn" @default.
Q38558536 description "2016年の論文" @default.
Q38558536 description "2016年論文" @default.
Q38558536 description "2016年論文" @default.
Q38558536 description "2016年論文" @default.
Q38558536 description "2016年論文" @default.
Q38558536 description "2016年論文" @default.
Q38558536 description "2016年论文" @default.
Q38558536 description "2016年论文" @default.
Q38558536 description "2016年论文" @default.
Q38558536 description "2016年论文" @default.
Q38558536 description "2016年论文" @default.
Q38558536 description "2016年论文" @default.
Q38558536 description "2016년 논문" @default.
Q38558536 description "article científic" @default.
Q38558536 description "article scientific" @default.
Q38558536 description "article scientifique" @default.
Q38558536 description "articol științific" @default.
Q38558536 description "articolo scientifico" @default.
Q38558536 description "artigo científico" @default.
Q38558536 description "artigo científico" @default.
Q38558536 description "artigo científico" @default.
Q38558536 description "artikel ilmiah" @default.
Q38558536 description "artikull shkencor" @default.
Q38558536 description "artikulong pang-agham" @default.
Q38558536 description "artykuł naukowy" @default.
Q38558536 description "artículo científico" @default.
Q38558536 description "artículu científicu espublizáu en 2016" @default.
Q38558536 description "bilimsel makale" @default.
Q38558536 description "bài báo khoa học" @default.
Q38558536 description "naučni članak" @default.
Q38558536 description "scienca artikolo" @default.
Q38558536 description "scientific article published on 29 December 2016" @default.
Q38558536 description "scientific article published on 29 December 2016" @default.
Q38558536 description "scientific article published on 29 December 2016" @default.
Q38558536 description "teaduslik artikkel" @default.
Q38558536 description "tieteellinen artikkeli" @default.
Q38558536 description "tudományos cikk" @default.
Q38558536 description "vedecký článok" @default.
Q38558536 description "vetenskaplig artikel" @default.
Q38558536 description "videnskabelig artikel" @default.
Q38558536 description "vitenskapelig artikkel" @default.
Q38558536 description "vitskapeleg artikkel" @default.
Q38558536 description "vědecký článek" @default.
Q38558536 description "wetenschappelijk artikel" @default.
Q38558536 description "wissenschaftlicher Artikel" @default.
Q38558536 description "επιστημονικό άρθρο" @default.
Q38558536 description "мақолаи илмӣ" @default.
Q38558536 description "наукова стаття, опублікована в грудні 2016" @default.
Q38558536 description "научна статия" @default.
Q38558536 description "научная статья" @default.
Q38558536 description "научни чланак" @default.
Q38558536 description "научни чланак" @default.
Q38558536 description "מאמר מדעי" @default.
Q38558536 description "مقالة علمية نشرت في 29 ديسمبر 2016" @default.
Q38558536 description "বৈজ্ঞানিক নিবন্ধ" @default.
Q38558536 description "บทความทางวิทยาศาสตร์" @default.
Q38558536 description "სამეცნიერო სტატია" @default.
Q38558536 name "Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-bl" @default.
Q38558536 name "Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-bl" @default.
Q38558536 name "Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-bl" @default.
Q38558536 type Item @default.
Q38558536 label "Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-bl" @default.
Q38558536 label "Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-bl" @default.
Q38558536 label "Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-bl" @default.
Q38558536 prefLabel "Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-bl" @default.
Q38558536 prefLabel "Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-bl" @default.
Q38558536 prefLabel "Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-bl" @default.
Q38558536 P1433 Q38558536-1DB086AF-C502-4F01-AA5B-AF02C0A64CE0 @default.
Q38558536 P1476 Q38558536-33B60046-0AE2-4F40-96EE-D8A173F54750 @default.
Q38558536 P2093 Q38558536-02F25137-1FDB-4B07-BDB5-90A01A3DC900 @default.
Q38558536 P2093 Q38558536-24E3FF41-0064-4562-803D-4D0D77B78B1B @default.
Q38558536 P2093 Q38558536-35120310-4804-4AE3-9025-1F5B16E3EFBD @default.
Q38558536 P2093 Q38558536-393CA459-12B1-44B7-A7F4-718C224537E6 @default.
Q38558536 P2093 Q38558536-63FBB3B5-A1C9-4CCD-9F23-B769C3554EDE @default.
Q38558536 P2093 Q38558536-72FA3970-70CE-4C97-8FBC-FDEA458095B0 @default.
Q38558536 P2093 Q38558536-D2820ACD-AFC3-40E5-92AE-02FB40A1D596 @default.
Q38558536 P2093 Q38558536-E032CBB5-26F3-45A1-A7E4-C991460CF5C3 @default.
Q38558536 P2093 Q38558536-F9056A2D-6994-49B7-ABED-040AEED09122 @default.
Q38558536 P304 Q38558536-B70B2C82-EBA1-4764-B472-9B14315B9B45 @default.
Q38558536 P31 Q38558536-32BC7509-7F05-4951-967C-4DF5B56B1031 @default.
Q38558536 P356 Q38558536-9628F348-9C6C-4DB1-BD84-C369ACF625A1 @default.
Q38558536 P407 Q38558536-B5BF5355-51E7-49F8-8711-155401FCF386 @default.
Q38558536 P433 Q38558536-796A1368-63C2-4EF8-94B6-C485101A1B43 @default.
Q38558536 P478 Q38558536-E0C4B1B7-B50E-4412-A488-95748827D981 @default.
Q38558536 P577 Q38558536-4C06F15A-EDE8-4DF5-B5ED-B4BB1660FDF8 @default.
Q38558536 P698 Q38558536-32444040-70CE-4219-91F7-F7B28C8269FA @default.
Q38558536 P921 Q38558536-172B0059-DA67-46B9-9F62-6F20B00695A8 @default.
Q38558536 P921 Q38558536-6B2492BF-2180-4463-A8DA-717550FEDBEE @default.
Q38558536 P921 Q38558536-D25A72A5-366A-4375-BA06-A1E8FCD2E646 @default.
Q38558536 P921 Q38558536-F8E0605D-0399-4F6F-923D-6AED609C4B1D @default.
Q38558536 P356 J.JAAD.2016.11.042 @default.
Q38558536 P698 28057361 @default.
Q38558536 P1433 Q15757046 @default.
Q38558536 P1476 "Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-bl" @default.
Q38558536 P2093 "April W Armstrong" @default.
Q38558536 P2093 "Bruce Randazzo" @default.
Q38558536 P2093 "Kenneth B Gordon" @default.
Q38558536 P2093 "Kristian Reich" @default.
Q38558536 P2093 "Michael Song" @default.